TheRas, Inc.
Palo Alto, US · Delaware corporation · 1 known investors
Founders & leadership
IE
Idan ElmelechExecutive
PB
Pedro BeltranExecutive
FM
Frank McCormickNamed on SEC filing
NK
Neil KumarNamed on SEC filing
EW
Eli WallaceNamed on SEC filing
RK
Raymond KelleherNamed on SEC filing
Board
MD
Investors · 1
Reported raises · per SEC filings
Form D private placements$200M disclosed across 1 round · 2024
▶$200MraisedMay 2024 · 15 investors · BiotechnologyRule 506(b)
▶$200MraisedMay 2024 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michelle DoigDirector
- Idan ElmelechExecutive Officer
- Pedro BeltranExecutive Officer
- Frank McCormickDirector
- Neil KumarDirector
- Eli WallaceExecutive Officer
- Raymond KelleherDirector
- Offering amount
- $200M
- Amount sold
- $200M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are TheRas, Inc.'s investors?
- TheRas, Inc.'s investors include Omega Funds.
- How much funding has TheRas, Inc. raised?
- TheRas, Inc. has disclosed $200M raised across 1 round.
- Where is TheRas, Inc. headquartered?
- TheRas, Inc. is headquartered in Palo Alto, US.